Sleeping Giants: Emerging Roles for the Fat Cadherins in Health and Disease

Medicinal Research Reviews

Volumn 34, Issue 1, 2014, Pages 190-221

  Sadeqzadeh, Elham ^a,b   De Bock, Charles E ^a,b   Thorne, Rick F ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Cancer; Cell adhesion; Cell motility; Fat cadherins; FAT1; FAT4; Hippo pathway

Indexed keywords

CADHERIN; EPIDERMAL GROWTH FACTOR; FAT CADHERINS; FAT1 CADHERIN; FAT2 CADHERIN; FAT3 CADHERIN; FAT4 CADHERIN; PROTEIN HOMER 3; UNCLASSIFIED DRUG; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL POLARITY; CELLULAR DISTRIBUTION; DROSOPHILA; GENETIC ASSOCIATION; GENETIC DISORDER; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MISSENSE MUTATION; MOLECULAR INTERACTION; MOLECULAR WEIGHT; MUTANT DROSOPHILA; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; VERTEBRATE;

CANCER; CELL ADHESION; CELL MOTILITY; FAT CADHERINS; FAT1; FAT4; HIPPO PATHWAY;

ANIMALS; CADHERINS; DISEASE; DROSOPHILA; FEMALE; MALE;

EID: 84894520085     PISSN: 01986325     EISSN: 10981128     Source Type: Journal    
DOI: 10.1002/med.21286     Document Type: Article

References (175)

1. Buda A, Pignatelli M. E-cadherin and the cytoskeletal network in colorectal cancer development and metastasis. Cell Commun Adhes 2011;18(6):133-143.
2. Foss B, Tronstad KJ, Bruserud O. Connexin-based signaling in acute myelogenous leukemia (AML). Biochim Biophys Acta 2010;1798(1):1-8.
3. Lee DB, Huang E, Ward HJ. Tight junction biology and kidney dysfunction. Am J Physiol Renal Physiol 2006;290(1):F20-F34.
4. Takeichi M. Functional correlation between cell adhesive properties and some cell surface proteins. J Cell Biol 1977;75(2 Pt 1):464-474.
5. Kemler R, Babinet C, Eisen H, Jacob F. Surface antigen in early differentiation. Proc Natl Acad Sci USA 1977;74(10):4449-4452.
6. Hyafil F, Babinet C, Jacob F. Cell-cell interactions in early embryogenesis: A molecular approach to the role of calcium. Cell 1981;26(3 Pt 1):447-454.
7. Nollet F, Kools P, van Roy F. Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol 2000;299(3):551-572.
8. Tanoue T, Takeichi M. New insights into Fat cadherins. J Cell Sci 2005;118:2347-2353.
9. Rock R, Schrauth S, Gessler M. Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila. Dev Dyn 2005;234(3):747-755.
10. Saburi S, Hester I, Fischer E, Pontoglio M, Eremina V, Gessler M, Quaggin SE, Harrison R, Mount R, McNeill H. Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease. Nat Genet 2008;40(8):1010-1015.
11. Hill E, Broadbent ID, Chothia C, Pettitt J. Cadherin superfamily proteins in Caenorhabditis elegans and Drosophila melanogaster. J Mol Biol 2001;305(5):1011-1024.
12. Castillejo-López C, Arias WM, Baumgartner S. The fat-like gene of Drosophila is the true orthologue of vertebrate fat cadherins and is involved in the formation of tubular organs. J Biol Chem 2004;279(23):24034-24043.
13. Mitsui K, Nakajima D, Ohara O, Nakayama M. Mammalian fat3: A large protein that contains multiple cadherin and EGF-like motifs. Biochem Biophys Res Commun 2002;290(4):1260-1266.
14. Down M, Power M, Smith SI, Ralston K, Spanevello M, Burns GF, Boyd AW. Cloning and expression of the large zebrafish protocadherin gene, Fat. Gene Expr Patterns 2005;5(4):483-490.
15. Hirano S, Takeichi M. Cadherins in brain morphogenesis and wiring. Physiol Rev 2012;92(2):597-634.
16. Mohr OL. Modifications of the sex-ratio through a sex-linked semi-lethal in Drosophila melanogaster. (Besides notes on an autosomal section deficiency.) Studia Mendeliana, ad centesimum diem natalem Gregorii Mendelii a grata patria celebrandum, adiuvante ministerio Pragensi edita. Brunn Czechoslovakia: Apud Typos; 1923:266-287.
17. Mohr OL. Exaggeration and Inhibition Phenomena encountered in the analysis of an autosomal dominant. Mol Gen Genet MGG 1929;50(1):113-200.
18. Morgan T. The physical basis of Heredity. Philadelphia and London: J.B. Lippincott Company;1919.
19. Bryant PJ. Experimental and genetic analysis of growth and cell proliferation in Drosophila imaginal discs. In: Loomis W, Ed. Genetic Regulation of Development. New York: Alan R. Liss, Inc;1987. p 339-372.
20. Bryant PJ, Huettner B, Held LI, Jr, Ryerse J, Szidonya J. Mutations at the fat locus interfere with cell proliferation control and epithelial morphogenesis in Drosophila. Dev Biol 1988;129(2):541-554.
21. Mahoney PA, Weber U, Onofrechuk P, Biessmann H, Bryant PJ, Goodman CS. The fat tumor suppressor gene in Drosophila encodes a novel member of the cadherin gene superfamily. Cell 1991;67(5):853-868.
22. Sopko R, McNeill H. The skinny on Fat: An enormous cadherin that regulates cell adhesion, tissue growth, and planar cell polarity. Curr Opin Cell Biol 2009;21(5):717-723.
23. Grusche FA, Richardson HE, Harvey KF. Upstream regulation of the hippo size control pathway. Curr Biol 2010;20(13):R574-R582.
24. Pan D. The hippo signaling pathway in development and cancer. Dev Cell 2010;19(4):491-505.
25. Halder G, Johnson RL. Hippo signaling: Growth control and beyond. Development 2011;138(1):9-22.
26. Staley BK, Irvine KD. Hippo signaling in Drosophila: Recent advances and insights. Dev Dyn 2012;241(1):3-15.
27. Harvey KF, Hariharan IK. The hippo pathway. Cold Spring Harb Perspect Biol 2012;4(8):a011288.
28. Bennett FC, Harvey KF. Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway. Curr Biol 2006;16(21):2101-2110.
29. Cho E, Feng Y, Rauskolb C, Maitra S, Fehon R, Irvine KD. Delineation of a Fat tumor suppressor pathway. Nat Genet 2006;38(10):1142-1150.
30. Silva E, Tsatskis Y, Gardano L, Tapon N, McNeill H. The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway. Curr Biol 2006;16(21):2081-2089.
31. Willecke M, Hamaratoglu F, Kango-Singh M, Udan R, Chen CL, Tao C, Zhang X, Halder G. The fat cadherin acts through the hippo tumor-suppressor pathway to regulate tissue size. Curr Biol 2006;16(21):2090-2100.
32. Oh H, Irvine KD. Yorkie: The final destination of Hippo signaling. Trends Cell Biol 2010;20(7):410-417.
33. Huang J, Wu S, Barrera J, Matthews K, Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 2005;122(3):421-434.
34. Oh H, Irvine KD. In vivo regulation of Yorkie phosphorylation and localization. Development 2008;135(6):1081-1088.
35. Wei X, Shimizu T, Lai ZC. Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila. EMBO J 2007;26(7):1772-1781.
36. McCartney BM, Kulikauskas RM, LaJeunesse DR, Fehon RG. The neurofibromatosis-2 homologue, Merlin, and the tumor suppressor expanded function together in Drosophila to regulate cell proliferation and differentiation. Development 2000;127(6):1315-1324.
37. Brittle AL, Repiso A, Casal J, Lawrence PA, Strutt D. Four-jointed modulates growth and planar polarity by reducing the affinity of dachsous for fat. Curr Biol 2010;20(9):803-810.
38. Cho E, Irvine KD. Action of fat, four-jointed, dachsous and dachs in distal-to-proximal wing signaling. Development 2004;131(18):4489-4500.
39. Matakatsu H, Blair SS. Interactions between Fat and dachsous and the regulation of planar cell polarity in the Drosophila wing. Development 2004;131(15):3785-3794.
40. Matakatsu H, Blair SS. Separating the adhesive and signaling functions of the Fat and dachsous protocadherins. Development 2006;133(12):2315-2324.
41. Rogulja D, Rauskolb C, Irvine KD. Morphogen control of wing growth through the Fat signaling pathway. Dev Cell 2008;15(2):309-321.
42. Simon MA, Xu A, Ishikawa HO, Irvine KD. Modulation of fat:dachsous binding by the cadherin domain kinase four-jointed. Curr Biol 2010;20(9):811-817.
43. Willecke M, Hamaratoglu F, Sansores-Garcia L, Tao C, Halder G. Boundaries of dachsous cadherin activity modulate the Hippo signaling pathway to induce cell proliferation. Proc Natl Acad Sci USA 2008;105(39):14897-14902.
44. Ishikawa HO, Takeuchi H, Haltiwanger RS, Irvine KD. Four-jointed is a Golgi kinase that phosphorylates a subset of cadherin domains. Science 2008;321(5887):401-404.
45. Matakatsu H, Blair SS. Separating planar cell polarity and Hippo pathway activities of the protocadherins Fat and Dachsous. Development 2012;139(8):1498-1508.
46. Mao Y, Kucuk B, Irvine KD. Drosophila lowfat, a novel modulator of Fat signaling. Development 2009;136(19):3223-3233.
47. Feng Y, Irvine KD. Processing and phosphorylation of the Fat receptor. Proc Natl Acad Sci USA 2009;106(29):11989-11994.
48. Yang CH, Axelrod JD, Simon MA. Regulation of frizzled by fat-like cadherins during planar polarity signaling in the Drosophila compound eye. Cell 2002;108(5):675-688.
49. Lawrence PA, Casal J, Struhl G. Cell interactions and planar polarity in the abdominal epidermis of Drosophila. Development 2004;131(19):4651-4664.
50. Casal J, Lawrence PA, Struhl G. Two separate molecular systems, dachsous/Fat and starry night/frizzled, act independently to confer planar cell polarity. Development 2006;133(22):4561-4572.
51. Axelrod JD. Progress and challenges in understanding planar cell polarity signaling. Semin Cell Dev Biol 2009;20(8):964-971.
52. Clark HF, Brentrup D, Schneitz K, Bieber A, Goodman C, Noll M. Dachsous encodes a member of the cadherin superfamily that controls imaginal disc morphogenesis in Drosophila. Genes Dev 1995;9(12):1530-1542.
53. Fanto M, Clayton L, Meredith J, Hardiman K, Charroux B, Kerridge S, McNeill H. The tumor-suppressor and cell adhesion molecule Fat controls planar polarity via physical interactions with Atrophin, a transcriptional co-repressor. Development 2003;130(4):763-774.
54. Napoletano F, Occhi S, Calamita P, Volpi V, Blanc E, Charroux B, Royet J, Fanto M. Polyglutamine Atrophin provokes neurodegeneration in Drosophila by repressing fat. EMBO J 2011;30(5):945-958.
55. Viktorinova I, Konig T, Schlichting K, Dahmann C. The cadherin Fat2 is required for planar cell polarity in the Drosophila ovary. Development 2009;136(24):4123-4132.
56. Viktorinova I, Pismen LM, Aigouy B, Dahmann C. Modelling planar polarity of epithelia: The role of signal relay in collective cell polarization. J R Soc Interface 2011;8(60):1059-1063.
57. Hou R, Liu L, Anees S, Hiroyasu S, Sibinga NE. The Fat1 cadherin integrates vascular smooth muscle cell growth and migration signals. J Cell Biol 2006;173(3):417-429.
58. Hou R, Sibinga NE. Atrophin proteins interact with the Fat1 cadherin and regulate migration and orientation in vascular smooth muscle cells. J Biol Chem 2009;284(11):6955-6965.
59. Moeller MJ, Soofi A, Braun GS, Li X, Watzl C, Kriz W, Holzman LB. Protocadherin FAT1 binds Ena/VASP proteins and is necessary for actin dynamics and cell polarization. EMBO J 2004;23(19):3769-3779.
60. Schreiner D, Müller K, Hofer HW. The intracellular domain of the human protocadherin hFat1 interacts with Homer signalling scaffolding proteins. FEBS Lett 2006;580(22):5295-5300.
61. Skouloudaki K, Puetz M, Simons M, Courbard JR, Boehlke C, Hartleben B, Engel C, Moeller MJ, Englert C, Bollig F, Schafer T, Ramachandran H, Mlodzik M, Huber TB, Kuehn EW, Kim E, Kramer-Zucker A, Walz G. Scribble participates in Hippo signaling and is required for normal zebrafish pronephros development. Proc Natl Acad Sci USA 2009;106(21):8579-8584.
62. Mao Y, Mulvaney J, Zakaria S, Yu T, Morgan KM, Allen S, Basson MA, Francis-West P, Irvine KD. Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-Fat4 signaling during mammalian development. Development 2011;138(5):947-957.
63. Ishiuchi T, Misaki K, Yonemura S, Takeichi M, Tanoue T. Mammalian Fat and dachsous cadherins regulate apical membrane organization in the embryonic cerebral cortex. J Cell Biol 2009;185(6):959-967.
64. Pan G, Feng Y, Ambegaonkar AA, Sun G, Huff M, Rauskolb C, Irvine KD. Signal transduction by the Fat cytoplasmic domain. Development 2013;140(4):831-842.
65. Jones C, Chen P. Planar cell polarity signaling in vertebrates. Bioessays 2007;29(2):120-132.
66. Sopko R, Silva E, Clayton L, Gardano L, Barrios-Rodiles M, Wrana J, Varelas X, Arbouzova NI, Shaw S, Saburi S, Matakatsu H, Blair S, McNeill H. Phosphorylation of the tumor suppressor fat is regulated by its ligand Dachsous and the kinase discs overgrown. Curr Biol 2009;19(13):1112-1117.
67. Lake RJ, Grimm LM, Veraksa A, Banos A, Artavanis-Tsakonas S. In vivo analysis of the Notch receptor S1 cleavage. PLoS ONE 2009;4(8):e6728.
68. Goodrich LV, Strutt D. Principles of planar polarity in animal development. Development 2011;138(10):1877-1892.
69. Vinson CR, Adler PN. Directional non-cell autonomy and the transmission of polarity information by the frizzled gene of Drosophila. Nature 1987;329(6139):549-551.
70. Vinson CR, Conover S, Adler PN. A Drosophila tissue polarity locus encodes a protein containing seven potential transmembrane domains. Nature 1989;338(6212):263-264.
71. Klingensmith J, Nusse R, Perrimon N. The Drosophila segment polarity gene dishevelled encodes a novel protein required for response to the wingless signal. Genes Dev 1994;8(1):118-130.
72. Theisen H, Purcell J, Bennett M, Kansagara D, Syed A, Marsh JL. Dishevelled is required during wingless signaling to establish both cell polarity and cell identity. Development 1994;120(2):347-360.
73. Gubb D, Green C, Huen D, Coulson D, Johnson G, Tree D, Collier S, Roote J. The balance between isoforms of the prickle LIM domain protein is critical for planar polarity in Drosophila imaginal discs. Genes Dev 1999;13(17):2315-2327.
74. Taylor J, Abramova N, Charlton J, Adler PN. Van Gogh: A new Drosophila tissue polarity gene. Genetics 1998;150(1):199-210.
75. Wolff T, Rubin GM. Strabismus, a novel gene that regulates tissue polarity and cell fate decisions in Drosophila. Development 1998;125(6):1149-1159.
76. Feiguin F, Hannus M, Mlodzik M, Eaton S. The ankyrin repeat protein Diego mediates frizzled-dependent planar polarization. Dev Cell 2001;1(1):93-101.
77. Chae J, Kim MJ, Goo JH, Collier S, Gubb D, Charlton J, Adler PN, Park WJ. The Drosophila tissue polarity gene starry night encodes a member of the protocadherin family. Development 1999;126(23):5421-5429.
78. Usui T, Shima Y, Shimada Y, Hirano S, Burgess RW, Schwarz TL, Takeichi M, Uemura T. Flamingo, a seven-pass transmembrane cadherin, regulates planar cell polarity under the control of Frizzled. Cell 1999;98(5):585-595.
79. Lawrence PA. Planar cell polarity: Fashioning solutions. Fly (Austin) 2011;5(2):126-128.
80. Ma D, Yang CH, McNeill H, Simon MA, Axelrod JD. Fidelity in planar cell polarity signalling. Nature 2003;421(6922):543-547.
81. Lawrence PA, Struhl G, Casal J. Planar cell polarity: One or two pathways? Nat Rev Genet 2007;8(7):555-563.
82. Thomas C, Strutt D. The roles of the cadherins Fat and dachsous in planar polarity specification in Drosophila. Dev Dyn 2012;241(1):27-39.
83. Tearle RG, Nusslein-Volhard C. Tubingen mutants and stock list. 1987; 66:209-269.
84. Gutzeit HO, Eberhardt W, Gratwohl E. Laminin and basement membrane-associated microfilaments in wild-type and mutant Drosophila ovarian follicles. J Cell Sci 1991;100(4):781-788.
85. Gates J. Drosophila egg chamber elongation: Insights into how tissues and organs are shaped. Fly 2012;6(4):213-227.
86. Fung S, Wang F, Chase M, Godt D, Hartenstein V. Expression profile of the cadherin family in the developing Drosophila brain. J Comp Neurol 2008;506(3):469-488.
87. Zartman JJ, Kanodia JS, Yakoby N, Schafer X, Watson C, Schlichting K, Dahmann C, Shvartsman SY. Expression patterns of cadherin genes in Drosophila oogenesis. Gene Expr Patterns 2009;9(1):31-36.
88. Horne-Badovinac S, Hill J, Gerlach G, 2nd, Menegas W, Bilder D. A screen for round egg mutants in Drosophila identifies tricornered, furry, and misshapen as regulators of egg chamber elongation. G3 (Bethesda) 2012;2(3):371-378.
89. Saburi S, Hester I, Goodrich L, McNeill H. Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity. Development 2012;139(10):1806-1820.
90. Atlas of Genetics and Cytogenetics in Oncology and Haematology. p FAT1 (FAT tumor suppressor homolog 1 (Drosophila)), http://atlasgeneticsoncology.org/Genes/FAT1/ID40533ch4q35.html. The website was accessed first in August 2012 and last on 30th of April 2013.
91. Dunne J, Hanby AM, Poulsom R, Jones TA, Sheer D, Chin WG, Da SM, Zhao Q, Beverley PC, Owen MJ. Molecular cloning and tissue expression of FAT, the human homologue of the Drosophila fat gene that is located on chromosome 4q34-q35 and encodes a putative adhesion molecule. Genomics 1995;30(2):207-223.
92. Cox B, Hadjantonakis AK, Collins JE, Magee AI. Cloning and expression throughout mouse development of mfat1, a homologue of the Drosophila tumour suppressor gene fat. Dev Dyn 2000;217(3):233-240.
93. Ponassi M, Jacques TS, Ciani L, ffrench Constant C. Expression of the rat homologue of the Drosophila fat tumour suppressor gene. Mech Dev 1999;80(2):207-212.
94. Smith TG, Van Hateren N, Tickle C, Wilson SA. The expression of Fat-1 cadherin during chick limb development. Int J Dev Biol 2007;51(2):173-176.
95. Nakayama M, Nakajima D, Yoshimura R, Endo Y, Ohara O. MEGF1/fat2 proteins containing extraordinarily large extracellular domains are localized to thin parallel fibers of cerebellar granule cells. Mol Cell Neurosci 2002;20(4):563-578.
96. Nagae S, Tanoue T, Takeichi M. Temporal and spatial expression profiles of the Fat3 protein, a giant cadherin molecule, during mouse development. Dev Dyn 2007;236(2):534-543.
97. Höng JC, Ivanov NV, Hodor P, Xia M, Wei N, Blevins R, Gerhold D, Borodovsky M, Liu Y. Identification of new human cadherin genes using a combination of protein motif search and gene finding methods. J Mol Biol 2004;337(2):307-317.
98. Yaoita E, Kurihara H, Yoshida Y, Inoue T, Matsuki A, Sakai T, Yamamoto T. Role of Fat1 in cell-cell contact formation of podocytes in puromycin aminonucleoside nephrosis and neonatal kidney. Kidney Int 2005;68(2):542-551.
99. Ciani L, Patel A, Allen ND, ffrench-Constant C. Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype. Mol Cell Biol 2003;23(10):3573-3582.
100. Inoue T, Yaoita E, Kurihara H, Shimizu F, Sakai T, Kobayashi T, Ohshiro K, Kawachi H, Okada H, Suzuki H, Kihara I, Yamamoto T. FAT is a component of glomerular slit diaphragms. Kidney Int 2001;59(3):1003-1012.
101. Boggon TJ, Murray J, Chappuis-Flament S, Wong E, Gumbiner BM, Shapiro L. C-cadherin ectodomain structure and implications for cell adhesion mechanisms. Science 2002;296(5571):1308-1313.
102. Leckband D, Prakasam A. Mechanism and dynamics of cadherin adhesion. Annu Rev Biomed Eng 2006;8:259-287.
103. Koch AW, Farooq A, Shan W, Zeng L, Colman DR, Zhou MM. Structure of the neural (N-) cadherin prodomain reveals a cadherin extracellular domain-like fold without adhesive characteristics. Structure 2004;12(5):793-805.
104. Magg T, Schreiner D, Solis GP, Bade EG, Hofer HW. Processing of the human protocadherin Fat1 and translocation of its cytoplasmic domain to the nucleus. Exp Cell Res 2005;307(1):100-108.
105. Thorne RF, Legg JW, Isacke CM. The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events. J Cell Sci 2004;117(Pt 3):373-380.
106. Tanoue T, Takeichi M. Mammalian Fat1 cadherin regulates actin dynamics and cell-cell contact. J Cell Biol 2004;165(4):517-528.
107. Bear JE, Svitkina TM, Krause M, Schafer DA, Loureiro JJ, Strasser GA, Maly IV, Chaga OY, Cooper JA, Borisy GG, Gertler FB. Antagonism between Ena/VASP proteins and actin filament capping regulates fibroblast motility. Cell 2002;109(4):509-521.
108. Niebuhr K, Ebel F, Frank R, Reinhard M, Domann E, Carl UD, Walter U, Gertler FB, Wehland J, Chakraborty T. A novel proline-rich motif present in ActA of Listeria monocytogenes and cytoskeletal proteins is the ligand for the EVH1 domain, a protein module present in the Ena/VASP family. EMBO J 1997;16(17):5433-5444.
109. Duncan RS, Hwang SY, Koulen P. Effects of Vesl/Homer proteins on intracellular signaling. Exp Biol Med (Maywood) 2005;230(8):527-535.
110. Huang G, Huso D, Bouyain S, Tu J, McCorkell K, May M, Zhu Y, Lutz M, Collins S, Dehoff M, Kang S, Whartenby K, Powell J, Leahy D, Worley P. NFAT binding and regulation of T cell activation by the cytoplasmic scaffolding Homer proteins. Science 2008;319(5862):476-481.
111. Ehlers MD. Molecular morphogens for dendritic spines. Trends Neurosci 2002;25(2):64-67.
112. Blair IP, Chetcuti AF, Badenhop RF, Scimone A, Moses MJ, Adams LJ, Craddock N, Green E, Kirov G, Owen MJ, Kwok JB, Donald JA, Mitchell PB, Schofield PR. Positional cloning, association analysis and expression studies provide convergent evidence that the cadherin gene FAT contains a bipolar disorder susceptibility allele. Mol Psychiatry 2006;11(4):372-383.
113. Willour VL, Zandi PP, Huo Y, Diggs TL, Chellis JL, MacKinnon DF, Simpson SG, McMahon FJ, Potash JB, Gershon ES, Reich T, Foroud T, Nurnberger JI, Jr, DePaulo JR, Jr, McInnis MG. Genome scan of the fifty-six bipolar pedigrees from the NIMH genetics initiative replication sample: Chromosomes 4, 7, 9, 18, 19, 20, and 21. Am J Med Genet B Neuropsychiatr Genet 2003;121B(1):21-27.
114. Braun GS, Kretzler M, Heider T, Floege J, Holzman LB, Kriz W, Moeller MJ. Differentially spliced isoforms of FAT1 are asymmetrically distributed within migrating cells. J Biol Chem 2007;282(31):22823-22833.
115. Shapiro IM, Cheng AW, Flytzanis NC, Balsamo M, Condeelis JS, Oktay MH, Burge CB, Gertler FB. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet 2011;7(8):e1002218.
116. Tiwari N, Gheldof A, Tatari M, Christofori G. EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol 2012;22(3):194-207.
117. Morris LG, Kaufman AM, Gong Y, Ramaswami D, Walsh LA, Turcan S, Eng S, Kannan K, Zou Y, Peng L, Banuchi VE, Paty P, Zeng Z, Vakiani E, Solit D, Singh B, Ganly I, Liau L, Cloughesy TC, Mischel PS, Mellinghoff IK, Chan TA. Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation. Nat Genet 2013;45(3):253-261.
118. Huang J, Wu S, Barrera J, Matthews K, Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 2005;122(3):421-434.
119. Hong W, Guan KL. The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway. Semin Cell Dev Biol 2012;23(7):785-793.
120. Varelas X, Miller BW, Sopko R, Song S, Gregorieff A, Fellouse FA, Sakuma R, Pawson T, Hunziker W, McNeill H, Wrana JL, Attisano L. The Hippo pathway regulates Wnt/beta-catenin signaling. Dev Cell 2010;18(4):579-591.
121. Nakayama M, Nakajima D, Nagase T, Nomura N, Seki N, Ohara O. Identification of high-molecular-weight proteins with multiple EGF-like motifs by motif-trap screening. Genomics 1998;51(1):27-34.
122. Matsui S, Utani A, Takahashi K, Mukoyama Y, Miyachi Y, Matsuyoshi N. Human Fat2 is localized at immature adherens junctions in epidermal keratinocytes. J Dermatol Sci 2007;48(3):233-236.
123. Matsui S, Utani A, Takahashi K, Mukoyama Y, Miyachi Y, Matsuyoshi N. Knockdown of Fat2 by siRNA inhibits the migration of human squamous carcinoma cells. J Dermatol Sci 2008;51(3):207-210.
124. Van Hateren NJ, Das RM, Hautbergue GM, Borycki AG, Placzek M, Wilson SA. FatJ acts via the Hippo mediator Yap1 to restrict the size of neural progenitor cell pools. Development 2011;138(10):1893-1902.
125. Fidler C, Nakayama M, Jabs EW, Cheng J-F, Strickson A, Ohara O, Wainscoat JS, Boultwood J. Physical mapping of the MEGF1 gene, human homologue of the Drosophila tumour suppressor gene fat, to the critical region of the 5q-syndrome. GeneScreen 2001;1(3):165-167.
126. Van Den Berghe H, Cassiman J-J, David G, Fryns J-P, Michaux J-L, Sokal G. Distinct haematological disorder with deletion of long arm of No. 5 chromosome. Nature 1974;251(5474):437-438.
127. Sokal G, Michaux J, Van Den Berghe H, Cordier A, Rodhain J, Ferrant A, Moriau M, De Bruyere M, Sonnet J. A new hematologic syndrome with a distinct karyotype: The 5 q-chromosome. Blood 1975;46(4):519-533.
128. Barlow JL, Drynan LF, Hewett DR, Holmes LR, Lorenzo-Abalde S, Lane AL, Jolin HE, Pannell R, Middleton AJ, Wong SH, Warren AJ, Wainscoat JS, Boultwood J, McKenzie AN. A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome. Nat Med 2010;16(1):59-66.
129. Deans MR, Krol A, Abraira VE, Copley CO, Tucker AF, Goodrich LV. Control of neuronal morphology by the atypical cadherin Fat3. Neuron 2011;71(5):820-832.
130. Curtin JA, Quint E, Tsipouri V, Arkell RM, Cattanach B, Copp AJ, Henderson DJ, Spurr N, Stanier P, Fisher EM, Nolan PM, Steel KP, Brown SD, Gray IC, Murdoch JN. Mutation of Celsr1 disrupts planar polarity of inner ear hair cells and causes severe neural tube defects in the mouse. Curr Biol 2003;13(13):1129-1133.
131. Wang Y, Guo N, Nathans J. The role of Frizzled3 and Frizzled6 in neural tube closure and in the planar polarity of inner-ear sensory hair cells. J Neurosci 2006;26:2147-2156.
132. Bossuyt W, Chen CL, Chen Q, Sudol M, McNeill H, Pan D, Kopp A, Halder G. An evolutionary shift in the regulation of the Hippo pathway between mice and flies. Oncogene 2013 Apr 8. doi: 10.1038/onc.2013.82. [Epub ahead of print].
133. Avruch J, Zhou D, Fitamant J, Bardeesy N. Mst1/2 signalling to Yap: Gatekeeper for liver size and tumour development. Br J Cancer 2011;104(1):24-32.
134. Zhang N, Bai H, David KK, Dong J, Zheng Y, Cai J, Giovannini M, Liu P, Anders RA, Pan D. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell 2010;19(1):27-38.
135. Ockey CH, Feldman GV, Macaulay ME, Delaney MJ. A large deletion of the long arm of chromosome No. 4 in a child with limb abnormalities. Arch Dis Child 1967;42(224):428-434.
136. Strehle EM, Bantock HM. The phenotype of patients with 4q-syndrome. Genet Couns 2003;14(2):195-205.
137. Striano P, Elia M, Castiglia L, Galesi O, Pelligra S, Striano S. A t(4;9)(q34;p22) translocation associated with partial epilepsy, mental retardation, and dysmorphism. Epilepsia 2005;46(8):1322-1324.
138. Keeling SL, Lee-Jones L, Thompson P. Interstitial deletion 4q32-34 with ulnar deficiency: 4q33 may be the critical region in 4q terminal deletion syndrome. Am J Med Genet 2001;99(2):94-98.
139. Kitsiou-Tzeli S, Sismani C, Koumbaris G, Ioannides M, Kanavakis E, Kolialexi A, Mavrou A, Touliatou V, Patsalis PC. Distal del(4) (q33) syndrome: Detailed clinical presentation and molecular description with array-CGH. Eur J Med Genet 2008;51(1):61-67.
140. Rinaldi R, De Bernardo C, Assumma M, Grammatico B, Buffone E, Poscente M, Grammatico P. Cytogenetic and molecular characterization of a de novo 4q24qter duplication and correlation to the associated phenotype. Am J Med Genet A 2003;118A(2):122-126.
141. Van Buggenhout G, Maas NM, Fryns JP, Vermeesch JR. A dysmorphic boy with 4qter deletion and 4q32.3-34.3 duplication: Clinical, cytogenetic, and molecular findings. Am J Med Genet A 2004;131(2):186-189.
142. Abou Jamra R, Becker T, Georgi A, Feulner T, Schumacher J, Stromaier J, Schirmbeck F, Schulze TG, Propping P, Rietschel M, Nothen MM, Cichon S. Genetic variation of the FAT gene at 4q35 is associated with bipolar affective disorder. Mol Psychiatry 2008;13(3):277-284.
143. Pae CU, Chiesa A, Mandelli L, De Ronchi D, Serretti A. No influence of FAT polymorphisms in response to aripiprazole. J Hum Genet 2010;55(1):32-36.
144. Mitra AB, Murty VV, Li RG, Pratap M, Luthra UK, Chaganti RS. Allelotype analysis of cervical carcinoma. Cancer Res 1994;54(16):4481-4487.
145. Sherwood JB, Shivapurkar N, Lin WM, Ashfaq R, Miller DS, Gazdar AF, Muller CY. Chromosome 4 deletions are frequent in invasive cervical cancer and differ between histologic variants. Gynecol Oncol 2000;79(1):90-96.
146. Backsch C, Rudolph B, Kühne-Heid R, Kalscheuer V, Bartsch O, Jansen L, Beer K, Meyer B, Schneider A, Dürst M. A region on human chromosome 4 (q35.1→qter) induces senescence in cell hybrids and is involved in cervical carcinogenesis. Genes Chromosomes Cancer 2005;43(3):260-272.
147. Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D. Allelotype of head and neck squamous cell carcinoma. Cancer Res 1994;54(5):1152-1155.
148. Polascik TJ, Cairns P, Chang WY, Schoenberg MP, Sidransky D. Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma. Cancer Res 1995;55(22):5396-5399.
149. Hammoud ZT, Kaleem Z, Cooper JD, Sundaresan RS, Patterson GA, Goodfellow PJ. Allelotype analysis of esophageal adenocarcinomas: Evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res 1996;56(19):4499-4502.
150. Piao Z, Park C, Park JH, Kim H. Deletion mapping of chromosome 4q in hepatocellular carcinoma. Int J Cancer 1998;79(4):356-360.
151. Shivapurkar N, Virmani AK, Wistuba, II, Milchgrub S, Mackay B, Minna JD, Gazdar AF. Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma. Clin Cancer Res 1999;5(1):17-23.
152. Shivapurkar N, Maitra A, Milchgrub S, Gazdar AF. Deletions of chromosome 4 occur early during the pathogenesis of colorectal carcinoma. Hum Pathol 2001;32(2):169-177.
153. Simons A, Schepens M, Forus A, Godager L, van Asseldonk M, Myklebost O, van Kessel AG. A novel chromosomal region of allelic loss, 4q32-q34, in human osteosarcomas revealed by representational difference analysis. Genes Chromosomes Cancer 1999;26(2):115-124.
154. Dijkman R, van Doorn R, Szuhai K, Willemze R, Vermeer MH, Tensen CP. Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities. Blood 2007;109(4):1720-1727.
155. Settakorn J, Kaewpila N, Burns GF, Leong AS. FAT, E-cadherin, beta catenin, HER 2/neu, Ki67 immuno-expression, and histological grade in intrahepatic cholangiocarcinoma. J Clin Pathol 2005;58(12):1249-1254.
156. Nakaya K, Yamagata HD, Arita N, Nakashiro KI, Nose M, Miki T, Hamakawa H. Identification of homozygous deletions of tumor suppressor gene FAT in oral cancer using CGH-array. Oncogene 2007;26(36):5300-5308.
157. Chosdol K, Misra A, Puri S, Srivastava T, Chattopadhyay P, Sarkar C, Mahapatra AK, Sinha S. Frequent loss of heterozygosity and altered expression of the candidate tumor suppressor gene "FAT" in human astrocytic tumors. BMC Cancer 2009;9:5.
158. Shivapurkar N, Sood S, Wistuba, II, Virmani AK, Maitra A, Milchgrub S, Minna JD, Gazdar AF. Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas. Cancer Res 1999;59(15):3576-3580.
159. Kwaepila N, Burns G, Leong AS. Immunohistological localisation of human FAT1 (hFAT) protein in 326 breast cancers. Does this adhesion molecule have a role in pathogenesis? Pathology 2006;38(2):125-131.
160. Sadeqzadeh E, de Bock CE, Zhang XD, Shipman KL, Scott NM, Song C, Yeadon T, Oliveira CS, Jin B, Hersey P, Boyd AW, Burns GF, Thorne RF. Dual processing of Fat1 cadherin by human melanoma cells generates distinct protein products. J Biol Chem 2011;286(32):28181-28191.
161. de Bock CE, Ardjmand A, Molloy TJ, Bone SM, Johnstone D, Campbell DM, Shipman KL, Yeadon TM, Holst J, Spanevello MD, Nelmes G, Catchpoole DR, Lincz LF, Boyd AW, Burns GF, Thorne RF. The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia. Leukemia 2012;26(5):918-926.
162. Döhner H, Bloomfield CD, Frizzera G, Frestedt J, Arthur DC. Recurring chromosome abnormalities in Hodgkin's disease. Genes Chromosomes Cancer 1992;5(4):392-398.
163. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, Velculescu VE, Kinzler KW, Vogelstein B, Iacobuzio-Donahue CA. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010;467(7319):1114-1117.
164. Nikolaev SI, Rimoldi D, Iseli C, Valsesia A, Robyr D, Gehrig C, Harshman K, Guipponi M, Bukach O, Zoete V, Michielin O, Muehlethaler K, Speiser D, Beckmann JS, Xenarios I, Halazonetis TD, Jongeneel CV, Stevenson BJ, Antonarakis SE. Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat Genet 2012;44(2):133-139.
165. Qi C, Zhu YT, Hu L, Zhu YJ. Identification of Fat4 as a candidate tumor suppressor gene in breast cancers. Int J Cancer 2009;124(4):793-798.
166. Lee S, Stewart S, Nagtegaal I, Luo J, Wu Y, Colditz G, Medina D, Allred DC. Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer. Cancer Res 2012;72(17):4574-4586.
167. de Bock CE, Ardjmand A, Molloy TJ, Bone SM, Johnstone D, Campbell DM, Shipman KL, Yeadon TM, Holst J, Spanevello MD, Nelmes G, Catchpoole DR, Lincz LF, Boyd AW, Burns GF, Thorne RF. The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia. Leukemia 2012;26(5):918-926.
168. Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 2011;121(7):2750-2767.
169. Wei X, Walia V, Lin JC, Teer JK, Prickett TD, Gartner J, Davis S, Stemke-Hale K, Davies MA, Gershenwald JE, Robinson W, Robinson S, Rosenberg SA, Samuels Y. Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet 2011;43(5):442-446.
170. Jones S, Zhang X, Parsons DW, Lin JC-H, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong S-M, Fu B, Lin M-T, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008;321(5897):1801-1806.
171. Li M, Zhao H, Zhang X, Wood LD, Anders RA, Choti MA, Pawlik TM, Daniel HD, Kannangai R, Offerhaus GJA, Velculescu VE, Wang L, Zhou S, Vogelstein B, Hruban RH, Papadopoulos N, Cai J, Torbenson MS, Kinzler KW. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet 2011;43(9):828-829.
172. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie T-X, Zhang J, Wang J, Zhang N, El-Naggar AK, Jasser SA, Weinstein JN, Treviño L, Drummond JA, Muzny DM, Wu Y, Wood LD, Hruban RH, Westra WH, Koch WM, Califano JA, Gibbs RA, Sidransky D, Vogelstein B, Velculescu VE, Papadopoulos N, Wheeler DA, Kinzler KW, Myers JN. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011;333(6046):1154-1157.
173. Zang ZJ, Cutcutache I, Poon SL, Zhang SL, McPherson JR, Tao J, Rajasegaran V, Heng HL, Deng N, Gan A, Lim KH, Ong CK, Huang D, Chin SY, Tan IB, Ng CC, Yu W, Wu Y, Lee M, Wu J, Poh D, Wan WK, Rha SY, So J, Salto-Tellez M, Yeoh KG, Wong WK, Zhu YJ, Futreal PA, Pang B, Ruan Y, Hillmer AM, Bertrand D, Nagarajan N, Rozen S, Teh BT, Tan P. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat Genet 2012;44(5):570-574.
174. Nordkvist A, Gustafsson H, Juberg-Ode M, Stenman G. Recurrent rearrangements of 11q14-22 in mucoepidermoid carcinoma. Cancer Genet Cytogenet 1994;74(2):77-83.
175. Rauskolb C, Pan G, Reddy BV, Oh H, Irvine KD. Zyxin links fat signaling to the hippo pathway. PLoS Biol 2011;9(6):e1000624.